Showing results (2001-2010 of 2,155) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|October 29, 2019
Rayleigh-half normal distribution for modeling tooth movement dataM M E Abd El-Monsef, M M Abd El-RaoufJournal of Biopharmaceutical Statistics|January 30, 2018
Cluster analysis for repeated data with dropout: Sensitivity analysis using a distal eventLiesbeth Bruckers, Geert Molenberghs, Bianca Pulinx, et al.Journal of Biopharmaceutical Statistics|January 23, 2018
Dual composite reference standards (dCRS) in molecular diagnostic research: A new approach to reduce bias in the presence of Imperfect referenceShaowu Tang, Parichehr Hemyari, Jesse A Canchola, et al.Journal of Biopharmaceutical Statistics|May 16, 2022
Joint comparison of the predictive values of multiple binary diagnostic tests: an extension of McNemar's testYougui WuJournal of Biopharmaceutical Statistics|May 20, 2022
Borrowing historical information to improve phase I clinical trials using meta-analytic-predictive priorsXin Chen, Jingyi Zhang, Qian Jiang, et al.Journal of Biopharmaceutical Statistics|May 9, 2022
On Reference-based Imputation for Analysis of Incomplete Repeated Binary EndpointsMan Jin, Yixin FangJournal of Biopharmaceutical Statistics|May 10, 2022
Confidence interval construction for proportion difference from partially validated series with two fallible classifiersShi-Fang Qiu, Li-Ming Wang, Man-Lai Tang, et al.Journal of Biopharmaceutical Statistics|March 19, 2020
Design optimization for dose-finding trials: a reviewJihane Aouni, Jean Noel Bacro, Gwladys Toulemonde, et al.Journal of Biopharmaceutical Statistics|March 13, 2020
Comparison of two treatments on a covariate variableTsai-Yu Lin, Chen-Tuo Liao, Chi-Rong Li, et al.Journal of Biopharmaceutical Statistics|September 23, 2020
Checkerboard: a Bayesian efficacy and toxicity interval design for phase I/II dose-finding trialsJun Yin, Ying YuanPageof 216